Programme
The educational programme features sessions presented by each global society.
Please note all programme times are Greenwich Mean Time (GMT)
| TIME | PROGRAMME |
|---|---|
| 08.00 – 08.05 | WELCOME |
| 08.05 – 09.05 |  |
| 08.05 – 08.20 | DRESS syndrome: A literature review and treatment algorithm |
| 08.20 – 08.35 | DRACMA’ guideline update 2024 – Milk supplement/replacement formulas for infants and toddlers with CMA |
| 08.35 – 08.50 | Standards for intravenous Rapid Drug Desensitisation Ricardo Madrigal |
| 08.50 – 09.05 | Panel Q&A |
| 09:05 – 09:20 | BREAK |
| 09.20 – 10.20 | COMPANY SYMPOSIUM |
| 10.20 – 11.20 |  |
| 10.20 – 10.35 | Lessons learned on the standardisation of oral food challenges |
| 10.35 – 10.50 | EAACI Strategy on immune modulation in allergic diseases |
| 10.50 – 11.05 | EAACI strategy for the precise management of antibiotic allergy and its impact on EU antibiotic resistance Maria Torres |
| 11.05 – 11.20 | Panel Q&A |
| 11.20 – 11.40 | BREAK |
| 11.40 – 13.00 | Presidents Forum Live meeting of the Presidents of the Partner Societies |
| 13.00 – 13.40 | BREAK |
| 13.40 – 14.40 | Company symposium |
| 14.40 – 15.40 |  |
| 14.40 – 14.55 | Allergy Psychology Cases Christina Jones |
| 14.55 – 15.10 | Eczema cases Carsten Flohr |
| 15.10 – 15.25 | Venom allergy cases |
| 15.25 – 15.40 | Panel Q&A |
| 15.40 – 15.55 | BREAK |
| 15.55 – 16.55 |  |
| 15.55 – 16.10 | Food Protein-Induced Enterocolitis Syndrome (FPIES): Current Status and Future Directions Carina Venter |
| 16.10 – 16.25 | Pollen-Food Allergy Syndrome: Consensus on Management |
| 16.25 – 16.40 | Omalizumab Treatment of Food Allergy Aikaterini Anagnostou |
| 16.40 – 16.55 | Panel Q&A |
| 16.55 – 17.10 | BREAK |
| 17.10 – 18.10 | Invited Partner Society |
| 17.10 – 17.25 | Title TBD |
| 17.25 – 17.40 | Title TBD |
| 17.40 – 17.55 | Title TBD |
| 17.55 – 18.10 | Panel Q&A |
| 18.10 – 18.15 | CLOSING AND PRESIDENTS’ REMARKS |
Accreditation and Designation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the British Society for Allergy & Clinical Immunology (BSACI). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 5.00 AMA PRA Category 5 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.